Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 5/20 | 0.54 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | PREP | P48147 | 5/20 | 0.48 |
| ▸ | DPP4 | P27487 | 1/20 | 0.48 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.48 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.46 |
| ▸ | KDM1A | O60341 | 1/20 | 0.45 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7264269 | 0.88 | FKBP1A (0.62) | FKBP1AACEPREPDPP4DPP8 | |
| Hydrochloric Acid SCHEMBL7265458 | 0.86 | FKBP1A (0.61) | FKBP1AACEPREP | |
| SCHEMBL28824228 | 0.83 | FKBP1A (0.52) | FKBP1AACEPREPDPP4DPP8 | |
| Glycyl Proline SCHEMBL29111044 | 0.81 | ACE (0.53) | FKBP1AACEPREPDPP4DPP8 | |
| SCHEMBL31549534 | 0.80 | POLB (0.46) | FKBP1AACEKDM1A | |
| SCHEMBL8306955 | 0.80 | CPT2 (0.50) | FKBP1AACEPREPKMT2A | |
| SCHEMBL20362648 | 0.78 | FKBP1A (0.66) | FKBP1AACEPREPCTRB1NPSR1 | |
| Hydrochloric Acid SCHEMBL10977531 | 0.78 | CTRB1 (0.54) | FKBP1AACEPREPKMT2ACTRB1 | |
| SCHEMBL29483482 | 0.78 | PREP (0.47) | FKBP1AACEPREPKMT2A | |
| SCHEMBL31348952 | 0.77 | PREP (0.46) | FKBP1AACEPREPDPP8KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743102-A1 | COLLAGEN PEPTIDE COMPOSITION AND USE THEREOF IN AMELIORATING NEUROLOGICAL CONDITIONS AND FIBROSIS | Rousselot BV (BE) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025088052-A1 | CYCLIC ANALOGUE OF GLYCINE-PROLINE FOR USE IN THE PREVENTION AND/OR TREATMENT OF MEDICAL IMPLANT-RELATED FIBROSIS | ROUSSELOT BV (BE) | 2025-05-01 | — | — | WO | disclosed |
| EP-4114428-A1 | ULINASTATIN POLYPEPTIDES | Diamedica USA Inc. (US) | 2023-01-11 | — | — | EP | disclosed |